Literature DB >> 15616288

New multiplex PCR for rapid detection of isoniazid-resistant Mycobacterium tuberculosis clinical isolates.

Laura Herrera-León1, Tamara Molina, Pilar Saíz, Juan Antonio Sáez-Nieto, Maria Soledad Jiménez.   

Abstract

In this study, we describe a multiplex PCR to detect a AGC-->ACC (serine to threonine) mutation in the katG gene and a -15 C-to-T substitution (inhA(C-15T)) at the 5' end of a presumed ribosome binding site in the promoter of the mabA-inhA operon. These mutations have been reported in the majority of previous studies as the most frequent mutations involved in the resistance to isoniazid (INH) of Mycobacterium tuberculosis clinical strains with high levels of resistance. The method was optimized and validated after an analysis of 30 M. tuberculosis clinical isolates with known sequences of the relevant part of the katG gene and the regulatory region of the mabA-inhA operon. We analyzed 297 INH-resistant M. tuberculosis isolates collected in Spain from 1996 to 2003 by PCR-restriction fragment length polymorphism (using the katG gene), DNA sequencing, and the newly developed multiplex PCR. The results were concordant for all 297 isolates tested. The analysis revealed that 204 (68.7%) of the isolates carried one or both of the mutations. This finding suggests that with further development this multiplex PCR will be able to detect the majority of the INH-resistant M. tuberculosis clinical isolates from Spain and other countries where a high frequency of similar mutations occur.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15616288      PMCID: PMC538849          DOI: 10.1128/AAC.49.1.144-147.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community.

Authors:  A Van Rie ; R Warren; I Mshanga; A M Jordaan; G D van der Spuy ; M Richardson; J Simpson; R P Gie; D A Enarson; N Beyers; P D van Helden ; T C Victor
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG.

Authors:  G Abate; S E Hoffner; V O Thomsen; H Miörner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-05       Impact factor: 3.267

3.  Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India.

Authors:  C Mani; N Selvakumar; S Narayanan; P R Narayanan
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

4.  Nosocomial outbreak of multidrug-resistant tuberculosis caused by a strain of Mycobacterium tuberculosis W-Beijing family in St. Petersburg, Russia.

Authors:  O Narvskaya; T Otten; E Limeschenko; N Sapozhnikova; O Graschenkova; L Steklova; A Nikonova; M L Filipenko; I Mokrousov; B Vyshnevskiy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-08-15       Impact factor: 3.267

5.  [Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation].

Authors:  G CANETTI; N RIST; J GROSSET
Journal:  Rev Tuberc Pneumol (Paris)       Date:  1963 Feb-Mar

6.  Differentiation of phylogenetically related slowly growing mycobacteria by their gyrB sequences.

Authors:  H Kasai; T Ezaki; S Harayama
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Detection of rifampin-resistant Mycobacterium tuberculosis in sputa by nested PCR-linked single-strand conformation polymorphism and DNA sequencing.

Authors:  B J Kim; K H Lee; B N Park; S J Kim; E M Park; Y G Park; G H Bai; S J Kim; Y H Kook
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

8.  Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain.

Authors:  M J Torres; A Criado; N Gónzalez; J C Palomares; J Aznar
Journal:  Int J Tuberc Lung Dis       Date:  2002-02       Impact factor: 2.373

9.  Prevalence of S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Dubai and Beirut.

Authors:  S Ahmad; E Fares; G F Araj; T D Chugh; A S Mustafa
Journal:  Int J Tuberc Lung Dis       Date:  2002-10       Impact factor: 2.373

10.  Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia.

Authors:  T Tracevska; I Jansone; L Broka; O Marga; V Baumanis
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

View more
  22 in total

1.  Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China.

Authors:  Min Zhang; Jun Yue; Yan-Ping Yang; Hong-Mei Zhang; Jian-Qiang Lei; Rui-Liang Jin; Xue-Lian Zhang; Hong-Hai Wang
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.

Authors:  J Esteban; A Ortiz; M S Jiménez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

3.  Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.

Authors:  Paolo Miotto; Federica Piana; Valeria Penati; Filippo Canducci; Giovanni Battista Migliori; Daniela Maria Cirillo
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.

Authors:  E T Y Leung; P L Ho; K Y Yuen; W L Woo; T H Lam; R Y Kao; W H Seto; W C Yam
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

5.  Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR.

Authors:  Hyeeun Bang; Sangjung Park; Joohwan Hwang; Hyunwoo Jin; Eunjin Cho; Dae Yoon Kim; Taeksun Song; Isdore Chola Shamputa; Laura E Via; Clifton E Barry; Sang-Nae Cho; Hyeyoung Lee
Journal:  J Med Microbiol       Date:  2011-05-19       Impact factor: 2.472

Review 6.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

7.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Combined Species Identification and Drug Sensitivity Testing in Mycobacteria.

Authors:  Pieter-Jan Ceyssens; Karine Soetaert; Markus Timke; An Van den Bossche; Katrin Sparbier; Koen De Cremer; Markus Kostrzewa; Marijke Hendrickx; Vanessa Mathys
Journal:  J Clin Microbiol       Date:  2016-12-21       Impact factor: 5.948

8.  First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance.

Authors:  Rocio Lopez-Alvarez; Claudia Badillo-Lopez; Jorge F Cerna-Cortes; Ivan Castillo-Ramirez; Sandra Rivera-Gutierrez; Addy C Helguera-Repetto; Diana Aguilar; Rogelio Hernandez-Pando; Sofia Samper; Jorge A Gonzalez-y-Merchand
Journal:  BMC Microbiol       Date:  2010-03-17       Impact factor: 3.605

9.  Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.

Authors:  Indra L Bergval; Anja R J Schuitema; Paul R Klatser; Richard M Anthony
Journal:  J Antimicrob Chemother       Date:  2009-07-04       Impact factor: 5.790

10.  Multidrug-resistant Mycobacterium tuberculosis strain from Equatorial Guinea detected in Spain.

Authors:  Patricia Gavín; Maria J Iglesias; Maria S Jiménez; Laura Herrera-Leon; Elena Rodríguez-Valín; Nalin Rastogi; Josefa March; Rosa González-Palacios; Elia Palenque; Rafael Ayarza; Elena Hurra; Isolina Campos-Herrero; María A Vitoria; María A Lezcano; María J Revillo; Carlos Martin; Sofía Samper
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.